기업, 미생물 유전체학

Illumina Statement on Novel Coronavirus

Illumina has enacted precautionary measures focusing on the health and safety of our employees, families, customers and communities.

Illumina Statement on Novel Coronavirus
2020년 3월 17일

With the global spread of SARS-CoV-2, Illumina has enacted precautionary measures focusing on the health and safety of our employees, families, customers and communities. To help protect Illumina employees and business continuity, we have proactively implemented efforts including limiting travel and attendance at meetings and conferences, and allowing employees to work remotely, where possible. We are closely monitoring the situation and will update our action plan to protect employees, keep customers running and support efforts to minimize the spread of the virus. To date, we have not experienced sustained supply chain or other operational delays. We will continue to monitor and update as the situation evolves, balancing the safety of our employees and the needs of our customers. 

 

 

최근 기사

When a worldwide community comes together
When a worldwide community comes together
Committed to accelerating precision medicine in China
Video: Committed to accelerating precision medicine in China
Tackling antimicrobial resistance, one genome at a time
Tackling antimicrobial resistance, one genome at a time